Hoppa till sidans huvudinnehåll
Vi hittar inte den utgåva du söker efter, kanske funkar den här lika bra?

Extending the Spectrum of Precompetitive Collaboration in Oncology Research

Workshop Summary

Häftad, Engelska, 2010

AvInstitute of Medicine,Board on Health Care Services,National Cancer Policy Forum,Erin Balogh,Sharyl J. Nass,Margie Patlak

649 kr

Tillfälligt slut


Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grown 13 percent each year since 1970 (a 50-fold increase), the number of new drugs approved annually is no greater now than it was 50 years ago. Over the past decade, skyrocketing costs and the complexity of the scientific knowledge upon which to develop new agents have provided incentives for alternative approaches to drug development, if we are to continue to improve clinical care and reduce mortality. These challenges create opportunities for improved collaboration between industry, academia, government, and philanthropic organizations at each stage in new drug development, marketing, and implementation. Perhaps the most appropriate initial step in addressing the need for collaboration is to consider more precompetitive relationships that allow sharing of scientific information to foster drug development.While these collaborative relationships in basic and preclinical research on drug targets and the early stages of clinical testing are acknowledged to be potentially important drivers for innovation and more rapid marketing of new agents, they also raise a number of concerns that must be addressed. For example, acknowledgment of academic productivity and independence and economic competitiveness must be considered and these challenges managed to foster a culture of collaboration. At the same time, regulatory issues, the need for standardization, and intellectual property concerns must be confronted if the current models for drug development are to be refined to encourage robust participation in precompetitive collaborations. Recognizing the growing importance of precompetitive collaborations in oncology drug development, as well as the challenges these innovative collaborations pose, the National Cancer Policy Forum of the Institute of Medicine held a workshop on February 9 and 10, 2010. This book is a summary of the workshop proceedings.

Produktinformation

  • Utgivningsdatum2010-09-15
  • Mått152 x 229 x 10 mm
  • Vikt240 g
  • FormatHäftad
  • SpråkEngelska
  • Antal sidor112
  • FörlagNational Academies Press
  • ISBN9780309156547
Hoppa över listan

Mer från samma författare

To Err Is Human

Institute of Medicine, Committee on Quality of Health Care in America, Molla S. Donaldson, Janet M. Corrigan, Linda T. Kohn

Häftad

869 kr

From Neurons to Neighborhoods

National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson

Häftad

499 kr

Bereavement

Institute of Medicine, Committee for the Study of Health Consequences of the Stress of Bereavement

Häftad

1 259 kr

New Vaccine Development

Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health

Häftad

1 019 kr

Physician Staffing for the VA

Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb

Häftad

629 kr

Hoppa över listan

Du kanske också är intresserad av

Cancer Care in Low-Resource Areas

and Medicine National Academies of Sciences, Engineering, Institute of Medicine, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Erin Balogh

Häftad

789 kr

National Cancer Policy Summit

Institute of Medicine, Board on Health Care Services, National Cancer Policy Forum, Erin Balogh, Sharyl J. Nass, Margie Patlak

Häftad

339 kr

Implementation of Lung Cancer Screening

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Erin Balogh

Häftad

789 kr

Drug Development Paradigm in Oncology

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Erin Balogh, Amanda Wagner Gee

Häftad

869 kr

Cancer Care in Low-Resource Areas

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Erin Balogh

Häftad

849 kr

Applying Big Data to Address the Social Determinants of Health in Oncology

and Medicine National Academies of Sciences, Engineering, Division on Engineering and Physical Sciences, Committee on Applied and Theoretical Statistics, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl J. Nass, Margie Patlak, Emily Zevon, Erin Balogh

Häftad

709 kr